Cost Of Sales Changement Date
ALKERMES USD 61.51M 1.75M 2023-09
Alnylam Pharmaceuticals USD 85.86M 1.55M 2023-12
Amarin USD 23.56M 361K 2023-09
ANI Pharmaceuticals USD 53.42M 5.32M 2023-12
Eisai JPY 36.43B 7.49B 2023-09
Emergent BioSolutions USD 381.2M 226.1M 2023-06
Esperion Therapeutics USD 13.38M 6.59M 2023-09
GlaxoSmithKline GBP 2.24B 343M 2023-09
Heron Therapeutics USD 18.21M 1.95M 2023-09
Insmed USD 18.44M 1.74M 2023-12
Ligand Pharmaceuticals USD 1.64M 1.84M 2023-12
Merck USD 3.34B 891M 2023-12
Nektar Therapeutics USD 12.43M 5.44M 2023-09
Neurocrine Biosciences USD 11.2M 300K 2023-09
Omeros USD 333K 9K 2021-09
Pacira USD 47.69M 7.94M 2023-12
Regeneron Pharmaceuticals USD 517M 80.6M 2023-12
Roche Holding CHF 7.62B 1.33B 2023-06
Surmodics USD 7.04M 118K 2023-09
Ultragenyx Pharmaceutical USD 12.05M 1.06M 2023-12
Veracyte USD 29.38M 1.77M 2023-12
Vertex Pharmaceuticals USD 318.7M 10.1M 2023-09



Heron Therapeutics Le Coût Des Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.